|
G |
Abhd4 |
abhydrolase domain containing 4, N-acyl phospholipase B |
increases expression |
ISO |
Methylnitrosourea results in increased expression of ABHD4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:27,697,384...27,716,013
Ensembl chr15:27,704,113...27,716,966
|
|
G |
Acly |
ATP citrate lyase |
increases expression |
EXP |
Methylnitrosourea results in increased expression of ACLY mRNA |
CTD |
PMID:16525678 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Actb |
actin, beta |
increases mutagenesis |
EXP |
Methylnitrosourea results in increased mutagenesis of ACTB gene |
CTD |
PMID:10767621 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Adamts1 |
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of ADAMTS1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
|
|
G |
Afp |
alpha-fetoprotein |
decreases response to substance |
EXP |
AFP protein modified form results in decreased susceptibility to Methylnitrosourea |
CTD |
PMID:16322315 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agtr1b |
angiotensin II receptor, type 1b |
increases expression |
EXP |
Methylnitrosourea results in increased expression of AGTR1B mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 2:102,844,969...102,920,232
Ensembl chr 2:102,844,969...102,920,232
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of AKR1B10 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of AKT1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of AKT1 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of AKT1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:15581186 PMID:22465879 PMID:25164625 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
multiple interactions |
EXP |
[Hexachlorobenzene co-treated with Methylnitrosourea] results in increased phosphorylation of AKT2 protein |
CTD |
PMID:22245120 |
|
NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:82,883,547...82,933,817
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of ALDH1A1 mRNA |
CTD |
PMID:25922126 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Angptl4 |
angiopoietin-like 4 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of ANGPTL4 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Ap3s1 |
adaptor related protein complex 3 subunit sigma 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of AP3S1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:39,462,728...39,531,622
Ensembl chr18:39,462,765...39,531,622
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of APAF1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
increases response to substance |
ISO |
APC gene mutant form results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:12096346 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Aqp1 |
aquaporin 1 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of AQP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:84,482,512...84,494,690
Ensembl chr 4:84,482,512...84,494,690
|
|
G |
Areg |
amphiregulin |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Estradiol] results in increased expression of AREG mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of AREG mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of AREG mRNA |
CTD |
PMID:20732338 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Asip |
agouti signaling protein |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of A gene |
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 3:143,473,584...143,561,170
Ensembl chr 3:143,555,696...143,561,171
|
|
G |
Asns |
asparagine synthetase (glutamine-hydrolyzing) |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of ASNS mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 4:35,784,995...35,803,474
Ensembl chr 4:35,785,237...35,803,423
|
|
G |
Atf1 |
activating transcription factor 1 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of ATF1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:131,361,962...131,404,677
Ensembl chr 7:131,362,450...131,404,670
|
|
G |
Atp6v1f |
ATPase H+ transporting V1 subunit F |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of ATP6V1F gene |
CTD |
PMID:16868089 |
|
NCBI chr 4:58,067,666...58,070,628
|
|
G |
Atr |
ATR serine/threonine kinase |
affects localization multiple interactions |
ISO |
Methylnitrosourea affects the localization of ATR protein MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein] |
CTD |
PMID:21285353 |
|
NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
|
|
G |
Aurka |
aurora kinase A |
multiple interactions increases expression decreases expression |
EXP ISO |
[Estrogens co-treated with Progesterone] inhibits the reaction [Methylnitrosourea results in increased expression of AURKA mRNA] Methylnitrosourea results in decreased expression of AURKA mRNA |
CTD |
PMID:12124350 PMID:27233451 |
|
NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390
|
|
G |
Aurkb |
aurora kinase B |
decreases phosphorylation |
ISO |
Methylnitrosourea results in decreased phosphorylation of AURKB protein |
CTD |
PMID:27233451 |
|
NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837
|
|
G |
Axin1 |
axin 1 |
decreases expression |
EXP |
N-methyl-N-nitrosourea decreases expression of Axin1 mRNA in colon |
RGD |
PMID:28032729 |
RGD:150530464 |
NCBI chr10:15,163,477...15,215,615
Ensembl chr10:15,163,684...15,215,615
|
|
G |
B3galt1 |
Beta-1,3-galactosyltransferase 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of B3GALT1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 3:52,253,413...52,826,508
Ensembl chr 3:52,253,618...52,825,313
|
|
G |
Bad |
BCL2-associated agonist of cell death |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAD mRNA |
CTD |
PMID:20732338 |
|
NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased expression of BAX protein; [Methylnitrosourea co-treated with Estradiol] results in decreased expression of BAX mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of BAX mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of BAX mRNA; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein]; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein] Methylnitrosourea results in increased expression of BAX mRNA; Methylnitrosourea results in increased expression of BAX protein |
CTD |
PMID:16011256 PMID:16047940 PMID:16168987 PMID:20732338 PMID:22465879 PMID:28688903 More...
|
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl10 |
BCL10, immune signaling adaptor |
increases expression |
EXP |
Methylnitrosourea results in increased expression of BCL10 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression increases expression |
EXP ISO |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein; [Methylnitrosourea co-treated with Estradiol] results in increased expression of BCL2 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of BCL2 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of BCL2 mRNA; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein] Methylnitrosourea results in increased expression of BCL2 mRNA |
CTD |
PMID:15240709 PMID:16011256 PMID:16047940 PMID:20732338 PMID:22465879 PMID:24463056 More...
|
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression |
EXP |
Methylnitrosourea results in increased expression of BDNF mRNA |
CTD |
PMID:28688903 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of BIRC5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Bmp5 |
bone morphogenetic protein 5 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of BMP5 gene |
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 8:76,517,164...76,639,925
Ensembl chr 8:76,517,164...76,639,925
|
|
G |
Bpnt1 |
3'(2'), 5'-bisphosphate nucleotidase 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of BPNT1 gene |
CTD |
PMID:16868089 |
|
NCBI chr13:96,865,634...96,893,506
Ensembl chr13:96,868,580...96,893,503
|
|
G |
Btg2 |
BTG anti-proliferation factor 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of BTG2 mRNA |
CTD |
PMID:21382384 |
|
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
|
|
G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
increases expression |
ISO |
Methylnitrosourea results in increased expression of BUB1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:115,020,254...115,051,650
Ensembl chr 3:115,020,254...115,051,650
|
|
G |
Capn1 |
calpain 1 |
decreases activity |
EXP |
Methylnitrosourea results in decreased activity of CAPN1 protein |
CTD |
PMID:17069801 |
|
NCBI chr 1:203,275,912...203,300,848
Ensembl chr 1:203,277,344...203,300,177
|
|
G |
Capn2 |
calpain 2 |
increases activity |
EXP |
Methylnitrosourea results in increased activity of CAPN2 protein |
CTD |
PMID:17069801 |
|
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
|
|
G |
Car2 |
carbonic anhydrase 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CAR2 mRNA |
CTD |
PMID:17341692 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO EXP |
MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]; MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]] [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP3 protein; [Methylnitrosourea co-treated with Estradiol] results in decreased expression of CASP3 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP3 mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of CASP3 mRNA |
CTD |
PMID:13679151 PMID:20732338 PMID:22465879 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp6 |
caspase 6 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CASP6 mRNA |
CTD |
PMID:28688903 |
|
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases expression |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in decreased activity of CASP8 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP8 mRNA Methylnitrosourea results in increased expression of CASP8 mRNA |
CTD |
PMID:20732338 PMID:22465879 PMID:28688903 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in decreased expression of CASP9 mRNA |
CTD |
PMID:20732338 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cbr1 |
carbonyl reductase 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CBR1 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
increases expression multiple interactions |
EXP ISO |
Methylnitrosourea results in increased expression of CCL2 mRNA Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein] |
CTD |
PMID:16822543 PMID:17412507 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CCL20 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CCL3 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CCL4 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CCL5 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
|
|
G |
Ccn2 |
cellular communication network factor 2 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of CCN2 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Ccn3 |
cellular communication network factor 3 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of CCN3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
|
|
G |
Ccna2 |
cyclin A2 |
increases expression decreases expression |
ISO |
Methylnitrosourea results in increased expression of CCNA2 mRNA; Methylnitrosourea results in increased expression of CCNA2 protein Methylnitrosourea results in decreased expression of CCNA2 |
CTD |
PMID:15870882 PMID:18593901 PMID:25270620 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CCNB1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression multiple interactions |
EXP |
Methylnitrosourea results in increased expression of CCND1 protein [Methylnitrosourea co-treated with Estradiol] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Estradiol] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of CCND1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of CCND1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CCND1 protein] |
CTD |
PMID:18155124 PMID:20732338 PMID:25164625 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd3 |
cyclin D3 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CCND3 protein |
CTD |
PMID:18155124 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Cd59b |
CD59b molecule |
multiple interactions decreases lipidation |
EXP |
[Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Methylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein Methylnitrosourea results in decreased lipidation of CD59 protein |
CTD |
PMID:19965957 PMID:20202993 PMID:27931811 |
|
NCBI chr 3:90,459,085...90,477,571
Ensembl chr 3:90,459,162...90,478,847
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions decreases expression |
EXP ISO |
[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 mRNA; [Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of CDH1 protein] Methylnitrosourea results in decreased expression of CDH1 mRNA |
CTD |
PMID:25164625 PMID:27221058 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 mRNA; [Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of CDH2 protein] |
CTD |
PMID:25164625 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdh22 |
cadherin 22 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of CDH22 mRNA |
CTD |
PMID:17341692 |
|
NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
decreases expression increases expression |
ISO EXP |
Methylnitrosourea results in decreased expression of CDK1 Methylnitrosourea results in increased expression of CDK1 mRNA Methylnitrosourea results in increased expression of CDK1 protein |
CTD |
PMID:15870882 PMID:16525678 PMID:18593901 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
increases activity |
EXP |
Methylnitrosourea results in increased activity of CDK2 protein |
CTD |
PMID:15581186 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk5r1 |
cyclin-dependent kinase 5 regulatory subunit 1 |
increases cleavage |
EXP |
Methylnitrosourea results in increased cleavage of CDK5R1 protein |
CTD |
PMID:17069801 |
|
NCBI chr10:65,484,266...65,485,467
Ensembl chr10:65,483,941...65,488,456
|
|
G |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of CDK5RAP1 gene |
CTD |
PMID:16868089 |
|
NCBI chr 3:142,838,081...142,872,669
Ensembl chr 3:142,708,028...142,872,677
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression decreases expression |
ISO EXP |
Methylnitrosourea results in increased expression of CDKN1A mRNA Methylnitrosourea results in decreased expression of CDKN1A protein |
CTD |
PMID:15581186 PMID:18593901 PMID:28688903 PMID:29110037 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cel |
carboxyl ester lipase |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CEL mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 3:11,883,532...11,891,035
Ensembl chr 3:11,883,532...11,891,035
|
|
G |
Cela2a |
chymotrypsin like elastase 2A |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CELA2A mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 5:154,126,879...154,136,630
Ensembl chr 5:154,126,878...154,136,632
|
|
G |
Cenpa |
centromere protein A |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of CENPA mRNA |
CTD |
PMID:27233451 |
|
NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675
|
|
G |
Cenpe |
centromere protein E |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CENPE mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:223,637,035...223,695,692
Ensembl chr 2:223,636,998...223,695,669
|
|
G |
Cep290 |
centrosomal protein 290 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of CEP290 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 7:35,310,071...35,399,388
Ensembl chr 7:35,310,199...35,399,392
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases phosphorylation multiple interactions |
ISO |
Methylnitrosourea results in increased phosphorylation of CHEK2 protein MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:21285353 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Ckap5 |
cytoskeleton associated protein 5 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CKAP5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:77,491,195...77,593,300
Ensembl chr 3:77,491,276...77,593,264
|
|
G |
Cldn7 |
claudin 7 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of CLDN7 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
|
|
G |
Clu |
clusterin |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CLU mRNA |
CTD |
PMID:17412507 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Col4a3 |
collagen type IV alpha 3 chain |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of COL4A3 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 9:83,875,849...84,004,955
Ensembl chr 9:83,875,561...84,001,895
|
|
G |
Col5a3 |
collagen type V alpha 3 chain |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of COL5A3 mRNA |
CTD |
PMID:17341692 |
|
NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853
|
|
G |
Cpt1c |
carnitine palmitoyltransferase 1c |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CPT1C mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:95,442,814...95,457,347
Ensembl chr 1:95,442,817...95,457,342
|
|
G |
Cradd |
CASP2 and RIPK1 domain containing adaptor with death domain |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of CRADD gene |
CTD |
PMID:16868089 |
|
NCBI chr 7:29,940,240...29,952,907
Ensembl chr 7:29,798,586...29,952,907
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased phosphorylation of CREB1 protein |
CTD |
PMID:34186418 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crem |
cAMP responsive element modulator |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CREM mRNA |
CTD |
PMID:17412507 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Crip2 |
cysteine-rich protein 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CRIP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:132,221,120...132,226,066
Ensembl chr 6:132,221,082...132,226,065
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions increases expression |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein] |
CTD |
PMID:16822543 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctcf |
CCCTC-binding factor |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of CTCF mRNA |
CTD |
PMID:25270620 |
|
NCBI chr19:33,521,726...33,571,124
Ensembl chr19:33,529,319...33,571,123
|
|
G |
Ctnnb1 |
catenin beta 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of CTNNB1 protein |
CTD |
PMID:12096346 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cwc27 |
CWC27 spliceosome associated cyclophilin |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of CWC27 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:35,764,674...35,975,908
Ensembl chr 2:35,764,686...35,975,872
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of CXCR1 gene |
CTD |
PMID:16868089 |
|
NCBI chr 9:75,766,894...75,771,079
Ensembl chr 9:75,766,770...75,771,084
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of CYP27B1 mRNA |
CTD |
PMID:21843606 |
|
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
|
|
G |
Cyp2j4 |
cytochrome P450, family 2, subfamily j, polypeptide 4 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of CYP2J9 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 5:111,179,981...111,207,490
Ensembl chr 5:111,178,703...111,244,794
|
|
G |
Dapk1 |
death associated protein kinase 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of DAPK1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:3,930,223...4,090,991
Ensembl chr17:3,930,213...4,090,991
|
|
G |
Dbi |
diazepam binding inhibitor |
increases expression |
EXP |
Methylnitrosourea results in increased expression of DBI mRNA |
CTD |
PMID:16525678 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of DBP mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Dcaf4 |
DDB1 and CUL4 associated factor 4 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of DCAF4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:103,154,847...103,180,992
Ensembl chr 6:103,154,867...103,180,982
|
|
G |
Ddit4l |
DNA-damage-inducible transcript 4-like |
increases expression |
ISO |
Methylnitrosourea results in increased expression of DDIT4L mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:226,128,273...226,131,044
Ensembl chr 2:226,128,276...226,131,375
|
|
G |
Depdc7 |
DEP domain containing 7 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of DEPDC7 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 3:91,099,111...91,121,152
Ensembl chr 3:91,099,835...91,121,124
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
multiple interactions |
EXP |
Methylnitrosourea inhibits the reaction [Iodine results in increased expression of DIO1 mRNA] |
CTD |
PMID:15922087 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Dlgap1 |
DLG associated protein 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of DLGAP1 gene |
CTD |
PMID:16868089 |
|
NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817
|
|
G |
Dmbt1 |
deleted in malignant brain tumors 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of DMBT1 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 1:185,617,469...185,696,476
Ensembl chr 1:185,617,294...185,696,478
|
|
G |
Dnajb5 |
DnaJ heat shock protein family (Hsp40) member B5 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of DNAJB5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:57,176,840...57,186,067
Ensembl chr 5:57,176,845...57,185,490
|
|
G |
Dnajc7 |
DnaJ heat shock protein family (Hsp40) member C7 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of DNAJC7 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:85,518,637...85,555,079
Ensembl chr10:85,518,621...85,555,575
|
|
G |
Dnpep |
aspartyl aminopeptidase |
decreases activity |
EXP |
Methylnitrosourea results in decreased activity of DNPEP protein |
CTD |
PMID:16537183 |
|
NCBI chr 9:76,799,931...76,808,841
Ensembl chr 9:76,783,966...76,808,716
|
|
G |
Dpysl3 |
dihydropyrimidinase-like 3 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of DPYSL3 mRNA |
CTD |
PMID:28688903 |
|
NCBI chr18:35,374,427...35,480,228
Ensembl chr18:35,377,181...35,480,157
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of DUSP5 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dym |
dymeclin |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of DYM gene |
CTD |
PMID:16868089 |
|
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of ECH1 gene |
CTD |
PMID:16868089 |
|
NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795
|
|
G |
Edf1 |
endothelial differentiation-related factor 1 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of EDF1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:8,377,058...8,381,363
Ensembl chr 3:8,366,613...8,381,363
|
|
G |
Ednrb |
endothelin receptor type B |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of EDNRB gene |
CTD |
PMID:17174358 |
|
NCBI chr15:80,640,839...80,672,115
Ensembl chr15:80,643,043...80,672,115
|
|
G |
Eed |
embryonic ectoderm development |
affects response to substance |
ISO |
EED protein affects the susceptibility to Methylnitrosourea |
CTD |
PMID:11803473 |
|
NCBI chr 1:143,867,875...143,895,008
Ensembl chr 1:143,867,875...143,894,974
|
|
G |
Efna3 |
ephrin A3 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of EFNA3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:174,729,192...174,738,111
Ensembl chr 2:174,729,764...174,738,736
|
|
G |
Efs |
embryonal Fyn-associated substrate |
increases expression |
ISO |
Methylnitrosourea results in increased expression of EFS mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:28,392,417...28,403,016
Ensembl chr15:28,392,187...28,401,902
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of EGFR protein; Hexachlorobenzene promotes the reaction [Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]]; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in increased phosphorylation of EGFR protein]; Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]; Methylnitrosourea promotes the reaction [Hexachlorobenzene promotes the reaction [EGFR protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [Hexachlorobenzene results in increased phosphorylation of EGFR protein]; Methylnitrosourea results in increased phosphorylation of and results in decreased expression of EGFR protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of and results in increased phosphorylation of EGFR protein] |
CTD |
PMID:22245120 PMID:25164625 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Egln3 |
egl-9 family hypoxia-inducible factor 3 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of EGLN3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:71,650,297...71,675,766
Ensembl chr 6:71,650,297...71,675,766
|
|
G |
Eif2s2 |
eukaryotic translation initiation factor 2 subunit beta |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of EIF2S2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:143,374,652...143,395,460
Ensembl chr 3:143,373,686...143,395,432
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:22465879 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of ELOVL6 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
|
|
G |
Eomes |
eomesodermin |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of EOMES mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:118,181,340...118,189,186
Ensembl chr 8:118,181,777...118,188,316
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of EPHX1 mRNA |
CTD |
PMID:21382384 |
|
NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Ercc4 |
ERCC excision repair 4, endonuclease catalytic subunit |
decreases expression increases expression |
ISO |
Methylnitrosourea results in decreased expression of ERCC4 mRNA Methylnitrosourea results in increased expression of ERCC4 mRNA |
CTD |
PMID:16616109 |
|
NCBI chr10:2,416,259...2,448,364
Ensembl chr10:2,419,038...2,448,369
|
|
G |
Ergic3 |
ERGIC and golgi 3 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of ERGIC3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:144,525,059...144,534,813
Ensembl chr 3:144,525,092...144,534,813
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions increases response to substance decreases phosphorylation |
EXP |
[bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA]; [bisphenol A co-treated with Diethylhexyl Phthalate] promotes the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein]; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 mRNA; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of ESR1 protein; [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene] results in decreased expression of ESR1 protein; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in decreased phosphorylation of ESR1 protein]; Methylnitrosourea inhibits the reaction [Hexachlorobenzene promotes the reaction [ESR1 protein binds to SRC protein]] ESR1 protein results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:15528971 PMID:16891317 PMID:22245120 PMID:34186418 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Ezr |
ezrin |
increases expression |
EXP |
Methylnitrosourea results in increased expression of EZR mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
|
|
G |
F3 |
coagulation factor III, tissue factor |
increases expression |
EXP |
Methylnitrosourea results in increased expression of F3 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of FABP3 mRNA |
CTD |
PMID:17341692 |
|
NCBI chr 5:142,651,962...142,658,707
Ensembl chr 5:142,651,956...142,658,718
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of FAIM2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fam187b |
family with sequence similarity 187, member B |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of FAM187B mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:86,205,234...86,219,542
Ensembl chr 1:86,205,218...86,219,917
|
|
G |
Fasn |
fatty acid synthase |
increases expression |
EXP |
Methylnitrosourea results in increased expression of FASN mRNA |
CTD |
PMID:16525678 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbp2 |
fructose-bisphosphatase 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of FBP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:2,236,088...2,253,702
Ensembl chr17:2,236,336...2,253,698
|
|
G |
Fbxo15 |
F-box protein 15 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of FBXO15 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:78,319,577...78,634,695
Ensembl chr18:78,319,534...78,390,765
|
|
G |
Fbxo5 |
F-box protein 5 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of FBXO5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:42,196,068...42,202,437
Ensembl chr 1:42,196,068...42,202,437
|
|
G |
Fgf1 |
fibroblast growth factor 1 |
multiple interactions |
EXP |
FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein]; FGF1 protein modified form inhibits the reaction [Methylnitrosourea results in increased expression of BAX protein] |
CTD |
PMID:16011256 |
|
NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
multiple interactions |
EXP |
Methylnitrosourea results in increased expression of and affects the localization of FGFR1 protein |
CTD |
PMID:15581186 |
|
NCBI chr16:66,491,930...66,547,161
Ensembl chr16:66,494,042...66,547,350
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
multiple interactions |
EXP |
Methylnitrosourea results in increased expression of and affects the localization of FGFR2 protein |
CTD |
PMID:15581186 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
multiple interactions |
EXP |
Methylnitrosourea results in increased expression of and affects the localization of FGFR4 protein |
CTD |
PMID:15581186 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Fhit |
fragile histidine triad diadenosine triphosphatase |
increases methylation decreases expression |
EXP |
Methylnitrosourea results in increased methylation of FHIT intron; Methylnitrosourea results in increased methylation of FHIT promoter Methylnitrosourea results in decreased expression of FHIT mRNA; Methylnitrosourea results in decreased expression of FHIT protein |
CTD |
PMID:15937960 PMID:17412507 |
|
NCBI chr15:13,935,029...15,442,620
Ensembl chr15:13,934,995...15,442,340
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
increases expression multiple interactions |
EXP |
Methylnitrosourea results in increased expression of FOS mRNA; Methylnitrosourea results in increased expression of FOS protein [tetramethylpyrazine affects the expression of FOS mRNA] which results in decreased susceptibility to Methylnitrosourea; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of FOS protein] |
CTD |
PMID:16168987 PMID:16268501 PMID:17412507 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxa1 |
forkhead box A1 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of FOXA1 mRNA |
CTD |
PMID:27221058 |
|
NCBI chr 6:75,099,907...75,136,534
Ensembl chr 6:75,103,503...75,136,188
|
|
G |
Foxa2 |
forkhead box A2 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of FOXA2 mRNA |
CTD |
PMID:27221058 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions decreases expression |
EXP |
Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in decreased expression of FSHB protein] |
CTD |
PMID:22245120 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Galnt16 |
polypeptide N-acetylgalactosaminyltransferase 16 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of GALNT16 gene |
CTD |
PMID:16868089 |
|
NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705
|
|
G |
Galnt6 |
polypeptide N-acetylgalactosaminyltransferase 6 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of GALNT6 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:131,789,836...131,828,077
Ensembl chr 7:131,789,839...131,819,661
|
|
G |
Gbp2 |
guanylate binding protein 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of GBP2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression decreases expression |
EXP |
Methylnitrosourea results in increased expression of GFAP protein Methylnitrosourea results in decreased expression of GFAP mRNA |
CTD |
PMID:18155124 PMID:28688903 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gh1 |
growth hormone 1 |
decreases response to substance |
EXP |
GH1 gene mutant form results in decreased susceptibility to Methylnitrosourea |
CTD |
PMID:12082019 |
|
NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
|
|
G |
Gjb1 |
gap junction protein, beta 1 |
decreases response to substance |
ISO |
GJB1 protein results in decreased susceptibility to Methylnitrosourea |
CTD |
PMID:17463168 |
|
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
|
|
G |
Glipr1l2 |
GLIPR1 like 2 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of GLIPR1L2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 7:47,533,009...47,546,737
Ensembl chr 7:47,515,623...47,546,014
|
|
G |
Gmcl1 |
germ cell-less 1, spermatogenesis associated |
increases expression |
ISO |
Methylnitrosourea results in increased expression of GMCL1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:119,140,598...119,179,891
Ensembl chr 4:119,140,598...119,179,881
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of GPX2 mRNA; Methylnitrosourea results in increased expression of GPX2 protein |
CTD |
PMID:18056462 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Grb14 |
growth factor receptor bound protein 14 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of GRB14 gene |
CTD |
PMID:16868089 |
|
NCBI chr 3:49,568,210...49,683,805
Ensembl chr 3:49,568,210...49,683,889
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
multiple interactions |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of GRB2 protein |
CTD |
PMID:22465879 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
decreases expression increases expression |
EXP |
Methylnitrosourea results in decreased expression of GRIN2A mRNA Methylnitrosourea results in increased expression of GRIN2A mRNA |
CTD |
PMID:28688903 |
|
NCBI chr10:5,629,683...6,053,262
Ensembl chr10:5,631,369...6,044,637
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in decreased expression of GSK3B protein] |
CTD |
PMID:25164625 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Methylnitrosourea results in increased expression of H2AX protein modified form |
CTD |
PMID:27233451 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hba-a2 |
hemoglobin alpha, adult chain 2 |
increases carbamoylation |
ISO |
Methylnitrosourea results in increased carbamoylation of HBA1 protein |
CTD |
PMID:15655799 |
|
NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392
|
|
G |
Hba-a3 |
hemoglobin alpha, adult chain 3 |
increases carbamoylation |
ISO |
Methylnitrosourea results in increased carbamoylation of HBA2 protein |
CTD |
PMID:15655799 |
|
NCBI chr10:15,311,637...15,312,481
Ensembl chr10:15,311,634...15,312,481
|
|
G |
Hbb |
hemoglobin subunit beta |
increases carbamoylation |
ISO |
Methylnitrosourea results in increased carbamoylation of HBB protein |
CTD |
PMID:15655799 |
|
NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012
|
|
G |
Hdac6 |
histone deacetylase 6 |
multiple interactions |
EXP |
[bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of HDAC6 protein |
CTD |
PMID:34186418 |
|
NCBI chr X:14,550,645...14,572,445
Ensembl chr X:14,551,044...14,572,441
|
|
G |
Hesx1 |
HESX homeobox 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of HESX1 gene |
CTD |
PMID:16868089 |
|
NCBI chr16:2,191,852...2,193,957
Ensembl chr16:2,191,852...2,193,957
|
|
G |
Hgf |
hepatocyte growth factor |
decreases expression multiple interactions |
ISO |
Methylnitrosourea results in decreased expression of HGF mRNA Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of HGF mRNA] |
CTD |
PMID:18675455 |
|
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
|
|
G |
Hist1h2bc |
histone cluster 1, H2bc |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of H2BC4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:42,692,335...42,696,601
Ensembl chr17:42,694,723...42,696,642
|
|
G |
Hivep2 |
HIVEP zinc finger 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of HIVEP2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 1:8,358,205...8,555,993
Ensembl chr 1:8,359,289...8,555,993
|
|
G |
Hmgb2 |
high mobility group box 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of HMGB2 mRNA; Methylnitrosourea results in increased expression of HMGB2 protein |
CTD |
PMID:16525678 PMID:29877212 |
|
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
|
|
G |
Hmgb3 |
high mobility group box 3 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of HMGB3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:149,296,303...149,301,290
Ensembl chr X:149,296,375...149,301,292
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of HMOX1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
increases mutagenesis increases expression |
EXP ISO |
Methylnitrosourea results in increased mutagenesis of HPRT1 gene Methylnitrosourea results in increased expression of HPRT1 mRNA |
CTD |
PMID:18249417 PMID:25270620 |
|
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
|
|
G |
Hras |
HRas proto-oncogene, GTPase |
multiple interactions decreases response to substance increases mutagenesis increases response to substance |
ISO EXP |
limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] HRAS protein results in decreased susceptibility to Methylnitrosourea Methylnitrosourea results in increased mutagenesis of HRAS gene |
CTD |
PMID:10767621 PMID:11182032 PMID:11376698 PMID:11802805 PMID:11973638 PMID:12117780 PMID:15688392 PMID:28421967 More...
|
|
NCBI chr 1:196,290,127...196,299,823
Ensembl chr 1:196,296,263...196,300,615
|
|
G |
Id3 |
inhibitor of DNA binding 3 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of ID3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:148,372,784...148,374,353
Ensembl chr 5:148,372,762...148,374,349
|
|
G |
Ier3 |
immediate early response 3 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of IER3 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases response to substance |
ISO EXP |
IFNG protein inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CCL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of CSF2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein] 2-Acetylaminofluorene inhibits the reaction [[Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein]; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IFNG protein IFNG protein results in decreased susceptibility to Methylnitrosourea |
CTD |
PMID:14736494 PMID:15240709 PMID:16080182 PMID:16822543 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
multiple interactions increases expression |
ISO |
Quercetin inhibits the reaction [Methylnitrosourea results in increased expression of IFRD1 mRNA] |
CTD |
PMID:18675455 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igdcc4 |
immunoglobulin superfamily, DCC subclass, member 4 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of IGDCC4 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:65,621,893...65,657,651
Ensembl chr 8:65,621,897...65,657,648
|
|
G |
Igf1 |
insulin-like growth factor 1 |
increases response to substance |
ISO |
IGF1 protein results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:15528971 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions increases expression |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of IGF1R protein; Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased expression of IGF1R protein] |
CTD |
PMID:16237195 PMID:22465879 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of IGFBP2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:74,415,574...74,442,945
Ensembl chr 9:74,415,546...74,442,937
|
|
G |
Ikzf1 |
IKAROS family zinc finger 1 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of IKZF1 mRNA |
CTD |
PMID:16616109 |
|
NCBI chr14:86,255,065...86,340,839
Ensembl chr14:86,255,065...86,342,416
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases expression increases expression |
ISO EXP |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in decreased expression of IL10 protein] Methylnitrosourea results in increased expression of IL10 mRNA; Methylnitrosourea results in increased expression of IL10 protein |
CTD |
PMID:14999141 PMID:16822543 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il17b |
interleukin 17B |
increases expression |
EXP |
Methylnitrosourea results in increased expression of IL17B mRNA |
CTD |
PMID:17341692 |
|
NCBI chr18:55,141,194...55,145,565
Ensembl chr18:55,141,194...55,145,565
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
ISO EXP |
Methylnitrosourea results in increased expression of IL1B mRNA Quercetin inhibits the reaction [Methylnitrosourea results in increased expression of IL1B mRNA] |
CTD |
PMID:17412507 PMID:18675455 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions increases expression |
ISO EXP |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL2 protein] [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with Butylhydroxybutylnitrosamine co-treated with diisopropanolnitrosamine co-treated with 1,2-Dimethylhydrazine] results in decreased expression of IL2 protein |
CTD |
PMID:14736494 PMID:16822543 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
multiple interactions increases expression |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of IL4 protein] |
CTD |
PMID:16822543 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Insr |
insulin receptor |
increases expression |
EXP |
Methylnitrosourea results in increased expression of INSR protein |
CTD |
PMID:16237195 |
|
NCBI chr12:1,193,193...1,330,976
Ensembl chr12:1,197,100...1,330,883
|
|
G |
Irf1 |
interferon regulatory factor 1 |
decreases response to substance increases expression |
ISO EXP |
IRF1 protein results in decreased susceptibility to Methylnitrosourea Methylnitrosourea results in increased expression of IRF1 mRNA |
CTD |
PMID:15240709 PMID:17412507 |
|
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
|
|
G |
Irs1 |
insulin receptor substrate 1 |
multiple interactions increases phosphorylation |
EXP |
Hexachlorobenzene inhibits the reaction [Methylnitrosourea results in increased phosphorylation of IRS1 protein] |
CTD |
PMID:16237195 |
|
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
|
|
G |
Jam2 |
junctional adhesion molecule 2 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of JAM2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:23,830,820...23,880,071
Ensembl chr11:23,831,106...23,880,063
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
increases expression increases phosphorylation multiple interactions |
EXP |
Methylnitrosourea results in increased expression of JUN protein Methylnitrosourea results in increased phosphorylation of JUN protein [tetramethylpyrazine affects the expression of JUN mRNA] which results in decreased susceptibility to Methylnitrosourea; Niacinamide inhibits the reaction [Methylnitrosourea results in increased expression of JUN protein]; Niacinamide inhibits the reaction [Methylnitrosourea results in increased phosphorylation of JUN protein] |
CTD |
PMID:16168987 PMID:16268501 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
increases expression |
EXP |
Methylnitrosourea results in increased expression of JUNB mRNA |
CTD |
PMID:17412507 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Kif3b |
kinesin family member 3B |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of KIF3B gene |
CTD |
PMID:16868089 |
|
NCBI chr 3:141,758,466...141,798,012
Ensembl chr 3:141,758,466...141,797,963
|
|
G |
Kitlg |
KIT ligand |
decreases expression multiple interactions |
ISO |
Methylnitrosourea results in decreased expression of KITL mRNA Quercetin inhibits the reaction [Methylnitrosourea results in decreased expression of KITL mRNA] |
CTD |
PMID:18675455 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klhl22 |
kelch-like family member 22 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of KLHL22 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr11:83,190,891...83,231,746
Ensembl chr11:83,190,891...83,231,770
|
|
G |
Klk1 |
kallikrein 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of KLK1 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
decreases response to substance increases mutagenesis |
EXP ISO |
KRAS protein results in decreased susceptibility to Methylnitrosourea Methylnitrosourea results in increased mutagenesis of KRAS gene |
CTD |
PMID:11973638 PMID:12483526 PMID:18062963 |
|
NCBI chr 4:178,185,418...178,218,484
|
|
G |
Lcn2 |
lipocalin 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of LCN2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
|
|
G |
Lep |
leptin |
multiple interactions increases expression |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of LEP protein] |
CTD |
PMID:16822543 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lgals3 |
galectin 3 |
decreases expression increases expression |
ISO EXP |
Methylnitrosourea results in decreased expression of LGALS3 mRNA N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum |
CTD RGD |
PMID:25270620 PMID:28032729 |
RGD:150530464 |
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
|
|
G |
Ltb |
lymphotoxin beta |
decreases response to substance |
ISO |
LTB protein results in decreased susceptibility to Methylnitrosourea |
CTD |
PMID:15240709 |
|
NCBI chr20:3,627,536...3,629,381
Ensembl chr20:3,627,537...3,629,381
|
|
G |
Macrod2 |
mono-ADP ribosylhydrolase 2 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of MACROD2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:127,720,066...129,737,511
Ensembl chr 3:127,720,181...129,734,492
|
|
G |
Mad2l2 |
mitotic arrest deficient 2 like 2 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of MAD2L2 gene |
CTD |
PMID:16868089 |
|
NCBI chr 5:158,563,545...158,576,698
Ensembl chr 5:158,563,567...158,576,693
|
|
G |
Madcam1 |
mucosal vascular addressin cell adhesion molecule 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of MADCAM1 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 7:10,036,301...10,039,703
Ensembl chr 7:10,036,301...10,039,703
|
|
G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
multiple interactions |
EXP |
Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAP2K1 protein |
CTD |
PMID:12693035 |
|
NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:64,683,449...64,755,147
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases response to substance multiple interactions |
EXP |
MAPK1 protein modified form results in increased susceptibility to Methylnitrosourea; MAPK1 protein results in increased susceptibility to Methylnitrosourea 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Methylnitrosourea results in increased activity of MAPK1 protein]; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK1 protein; [Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK1 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:12693035 PMID:15528971 PMID:22465879 PMID:25164625 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
EXP |
Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK14 protein |
CTD |
PMID:12693035 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases response to substance multiple interactions |
EXP |
MAPK3 protein modified form results in increased susceptibility to Methylnitrosourea; MAPK3 protein results in increased susceptibility to Methylnitrosourea 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Methylnitrosourea results in increased activity of MAPK3 protein]; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MAPK3 protein; [Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK3 protein; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK3 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:12693035 PMID:15528971 PMID:22465879 PMID:25164625 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions decreases response to substance increases activity increases phosphorylation |
ISO EXP |
Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased activity of MAPK8 protein]; MAPK8 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein] MAPK8 gene mutant form results in decreased susceptibility to Methylnitrosourea Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased activity of MAPK8 protein]; Methylnitrosourea results in increased phosphorylation of and results in increased activity of MAPK8 protein; Niacinamide inhibits the reaction [Methylnitrosourea results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:12693035 PMID:16168987 PMID:18593901 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapkapk3 |
MAPK activated protein kinase 3 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of MAPKAPK3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:107,929,754...107,963,638
Ensembl chr 8:107,929,762...107,963,568
|
|
G |
Mbp |
myelin basic protein |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of MBP mRNA |
CTD |
PMID:17341692 |
|
NCBI chr18:75,855,878...75,966,404
Ensembl chr18:75,855,878...75,966,404
|
|
G |
Mcam |
melanoma cell adhesion molecule |
increases expression |
ISO |
Methylnitrosourea results in increased expression of MCAM mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:44,479,391...44,487,575
Ensembl chr 8:44,479,376...44,487,571
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
increases expression |
EXP |
Methylnitrosourea results in increased expression of MDM2 mRNA |
CTD |
PMID:28688903 |
|
NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
|
|
G |
Me1 |
malic enzyme 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of ME1 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 8:87,549,043...87,660,251
Ensembl chr 8:87,549,043...87,660,304
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
increases alkylation multiple interactions decreases response to substance increases expression |
ISO EXP |
Methylnitrosourea results in increased alkylation of MGMT protein MGMT protein results in decreased susceptibility to [Methylnitrosourea co-treated with 9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]; MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea]; MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]; MLH1 protein promotes the reaction [MGMT protein results in decreased susceptibility to Methylnitrosourea] Methylnitrosourea results in increased expression of MGMT mRNA |
CTD |
PMID:8823159 PMID:11276365 PMID:11536039 PMID:12663516 PMID:13679151 PMID:15870882 PMID:17507295 PMID:23288051 PMID:28688903 More...
|
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mipol1 |
mirror-image polydactyly 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of MIPOL1 gene |
CTD |
PMID:16868089 |
|
NCBI chr 6:74,755,293...75,090,403
Ensembl chr 6:74,755,395...75,086,811
|
|
G |
Mir185 |
microRNA 185 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of MIR185 mRNA |
CTD |
PMID:30336191 |
|
NCBI chr11:82,664,716...82,664,795
Ensembl chr11:82,664,716...82,664,795
|
|
G |
Mir96 |
microRNA 96 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of MIR96 mRNA |
CTD |
PMID:30336191 |
|
NCBI chr 4:58,788,411...58,788,516
Ensembl chr 4:58,788,411...58,788,516
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of MKI67 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
|
|
G |
Mlf1 |
myeloid leukemia factor 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of MLF1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 2:151,648,492...151,681,654
Ensembl chr 2:151,648,511...151,681,652
|
|
G |
Mlh1 |
mutL homolog 1 |
multiple interactions affects response to substance |
ISO |
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein] MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]; MLH1 protein promotes the reaction [MGMT protein results in decreased susceptibility to Methylnitrosourea] MLH1 protein affects the susceptibility to Methylnitrosourea |
CTD |
PMID:12967659 PMID:13679151 PMID:16204460 |
|
NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617
|
|
G |
Mlx |
MAX dimerization protein MLX |
increases expression |
ISO |
Methylnitrosourea results in increased expression of MLX mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:86,019,216...86,024,326
Ensembl chr10:86,019,588...86,032,350
|
|
G |
Mmp3 |
matrix metallopeptidase 3 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of MMP3 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 8:4,640,397...4,653,963
Ensembl chr 8:4,640,416...4,653,961
|
|
G |
Mpc1 |
mitochondrial pyruvate carrier 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of MPC1 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 1:52,437,745...52,449,399
Ensembl chr 1:52,437,741...52,449,400
|
|
G |
Mpg |
N-methylpurine-DNA glycosylase |
decreases response to substance increases response to substance |
ISO |
MPG protein results in decreased susceptibility to Methylnitrosourea MPG protein results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:15299078 PMID:16288039 PMID:17674369 |
|
NCBI chr10:15,396,246...15,402,528
Ensembl chr10:15,395,782...15,402,520
|
|
G |
Mrpl47 |
mitochondrial ribosomal protein L47 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of MRPL47 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:115,507,842...115,520,093
Ensembl chr 2:115,500,264...115,518,994
|
|
G |
Mrps31 |
mitochondrial ribosomal protein S31 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of MRPS31 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr16:69,601,349...69,621,609
Ensembl chr16:69,601,349...69,630,654
|
|
G |
Msc |
musculin |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of MSC mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:4,547,335...4,553,206
Ensembl chr 5:4,547,405...4,553,203
|
|
G |
Msh2 |
mutS homolog 2 |
multiple interactions affects response to substance increases response to substance |
ISO |
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein]; Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] MSH2 protein promotes the reaction [Methylnitrosourea affects the localization of ATR protein]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of CHEK2 protein]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein] MSH2 protein affects the susceptibility to Methylnitrosourea MSH2 protein results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:12185594 PMID:16204460 PMID:21285353 |
|
NCBI chr 6:6,813,793...6,872,960
Ensembl chr 6:6,813,795...6,872,938
|
|
G |
Msh6 |
mutS homolog 6 |
multiple interactions |
ISO |
Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] |
CTD |
PMID:16204460 |
|
NCBI chr 6:6,562,631...6,579,995
Ensembl chr 6:6,562,632...6,579,956
|
|
G |
Mt1 |
metallothionein 1 |
multiple interactions increases expression |
ISO |
[Methylnitrosourea co-treated with Carrageenan] results in increased expression of MT1 protein Methylnitrosourea results in increased expression of MT1 protein |
CTD |
PMID:15928667 |
|
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
|
|
G |
Mthfd2 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of MTHFD2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 4:115,811,135...115,822,663
Ensembl chr 4:115,811,139...115,822,608
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
multiple interactions |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of MTOR protein; [Methylnitrosourea co-treated with Testosterone] results in increased expression of MTOR protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of MTOR protein] |
CTD |
PMID:22465879 PMID:25164625 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases expression decreases expression multiple interactions |
ISO EXP |
Methylnitrosourea results in increased expression of MYC mRNA Methylnitrosourea results in decreased expression of MYC mRNA [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with bisphenol A co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC mRNA; [Diethylhexyl Phthalate co-treated with Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein; [Diethylnitrosamine co-treated with Methylnitrosourea co-treated with diisopropanolnitrosamine] results in increased expression of MYC protein |
CTD |
PMID:16616109 PMID:17412507 PMID:25270620 PMID:34186418 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myo5a |
myosin VA |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of MYO5A gene |
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 8:75,811,985...75,980,049
Ensembl chr 8:75,812,412...75,975,918
|
|
G |
Ncor2 |
nuclear receptor co-repressor 2 |
affects expression |
EXP |
Methylnitrosourea affects the expression of NCOR2 mRNA |
CTD |
PMID:21843606 |
|
NCBI chr12:31,466,418...31,628,319
Ensembl chr12:31,466,412...31,628,319
|
|
G |
Nectin1 |
nectin cell adhesion molecule 1 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of NECTIN1 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 8:44,101,776...44,164,863
Ensembl chr 8:44,101,776...44,189,787
|
|
G |
Nes |
nestin |
increases expression increases methylation |
EXP ISO |
Methylnitrosourea results in increased expression of NES protein Methylnitrosourea results in increased methylation of NES gene |
CTD |
PMID:18155124 PMID:25922126 |
|
NCBI chr 2:173,437,867...173,447,777
Ensembl chr 2:173,438,734...173,447,777
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions increases expression |
EXP |
[Methylnitrosourea results in increased expression of NFKBIA protein] which affects the localization of RELA protein; tetramethylpyrazine inhibits the reaction [Methylnitrosourea results in increased expression of NFKBIA protein] |
CTD |
PMID:15960898 PMID:16098260 PMID:16762860 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Nme5 |
NME/NM23 family member 5 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of NME5 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:26,163,558...26,180,742
Ensembl chr18:26,163,555...26,180,794
|
|
G |
Nnat |
neuronatin |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of NNAT mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 3:146,225,941...146,228,868
Ensembl chr 3:146,226,407...146,228,834
|
|
G |
Nos2 |
nitric oxide synthase 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of NOS2 protein |
CTD |
PMID:16052507 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nrxn3 |
neurexin 3 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of NRXN3 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 6:107,641,760...109,272,849
Ensembl chr 6:107,641,780...109,272,044
|
|
G |
Ntm |
neurotrimin |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of NTM mRNA |
CTD |
PMID:25922126 |
|
NCBI chr 8:27,376,582...28,366,604
Ensembl chr 8:27,377,773...28,366,595
|
|
G |
Nusap1 |
nucleolar and spindle associated protein 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of NUSAP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:106,603,273...106,633,428
Ensembl chr 3:106,603,289...106,633,624
|
|
G |
Oaf |
out at first homolog |
increases expression |
EXP |
Methylnitrosourea results in increased expression of OAF mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 8:43,594,362...43,612,334
Ensembl chr 8:43,594,363...43,612,334
|
|
G |
Oca2 |
OCA2 melanosomal transmembrane protein |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of OCA2 gene |
CTD |
PMID:10517996 PMID:17174358 |
|
NCBI chr 1:107,116,278...107,446,093
Ensembl chr 1:107,116,278...107,446,074
|
|
G |
Ogfrl1 |
opioid growth factor receptor-like 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of OGFRL1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 9:25,828,865...25,842,424
Ensembl chr 9:25,828,869...25,842,352
|
|
G |
Opn4 |
opsin 4 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of OPN4 mRNA; Methylnitrosourea results in decreased expression of OPN4 protein |
CTD |
PMID:16580133 |
|
NCBI chr16:9,920,408...9,929,580
Ensembl chr16:9,920,491...10,005,711
|
|
G |
Pafah2 |
platelet-activating factor acetylhydrolase 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PAFAH2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:146,607,050...146,636,203
Ensembl chr 5:146,613,498...146,634,943
|
|
G |
Parg |
poly (ADP-ribose) glycohydrolase |
increases response to substance |
ISO |
PARG gene mutant form results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:15282315 |
|
NCBI chr16:7,436,429...7,544,276
Ensembl chr16:7,436,476...7,544,273
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases response to substance multiple interactions affects response to substance increases activity |
ISO EXP |
PARP1 gene mutant form results in increased susceptibility to Methylnitrosourea PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the expression of TRP53 protein]; PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] PARP1 protein affects the susceptibility to Methylnitrosourea Methylnitrosourea results in increased activity of PARP1 protein Niacinamide inhibits the reaction [Methylnitrosourea results in increased activity of PARP1 protein] |
CTD |
PMID:11850828 PMID:15282315 PMID:16052507 PMID:16168987 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Parp2 |
poly (ADP-ribose) polymerase 2 |
increases response to substance |
ISO |
PARP2 gene mutant form results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:12727891 |
|
NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338
|
|
G |
Patj |
PATJ, crumbs cell polarity complex component |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PATJ mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 5:113,061,985...113,364,807
Ensembl chr 5:113,062,118...113,364,807
|
|
G |
Pbk |
PDZ binding kinase |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PBK mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014
|
|
G |
Pc |
pyruvate carboxylase |
increases expression |
EXP |
Methylnitrosourea results in increased expression of PC mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions increases expression |
ISO EXP |
Methylnitrosourea promotes the reaction [MSH2 protein binds to PCNA protein binds to MSH6 protein] Methylnitrosourea results in increased expression of PCNA protein [Methylnitrosourea co-treated with Testosterone] results in increased expression of PCNA protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of PCNA protein] |
CTD |
PMID:16204460 PMID:18155124 PMID:25164625 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pdk1 |
pyruvate dehydrogenase kinase 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of PDK1 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 3:56,705,824...56,733,040
Ensembl chr 3:56,705,871...56,733,038
|
|
G |
Pdpk1 |
3-phosphoinositide dependent protein kinase-1 |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of PDPK1 protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased phosphorylation of PDPK1 protein] |
CTD |
PMID:25164625 |
|
NCBI chr10:13,105,435...13,182,664
Ensembl chr10:13,105,498...13,174,623
|
|
G |
Perp |
p53 apoptosis effector related to PMP22 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PERP mRNA |
CTD |
PMID:21382384 PMID:25270620 |
|
NCBI chr 1:13,542,067...13,554,514
Ensembl chr 1:13,542,067...13,554,511
|
|
G |
Pfkp |
phosphofructokinase, platelet |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of PFKP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Phlda3 |
pleckstrin homology-like domain, family A, member 3 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PHLDA3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:47,193,250...47,196,335
Ensembl chr13:47,193,086...47,196,335
|
|
G |
Pias2 |
protein inhibitor of activated STAT, 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PIAS2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:70,608,034...70,714,295
Ensembl chr18:70,607,665...70,710,033
|
|
G |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of PIEZO1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr19:50,544,580...50,606,812
Ensembl chr19:50,544,582...50,606,501
|
|
G |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
multiple interactions increases mutagenesis |
EXP |
[Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein] which affects the localization of CD59 protein; [Methylnitrosourea results in increased mutagenesis of PIGA gene] which results in decreased expression of CD59 protein; Methylnitrosourea results in increased mutagenesis of and results in decreased activity of PIGA protein Methylnitrosourea results in increased mutagenesis of PIGA; Methylnitrosourea results in increased mutagenesis of PIGA gene |
CTD |
PMID:19965957 PMID:20202993 PMID:22923490 PMID:27931811 |
|
NCBI chr X:30,043,033...30,055,861
Ensembl chr X:30,042,343...30,055,804
|
|
G |
Pinx1 |
PIN2/TERF1 interacting, telomerase inhibitor 1 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of PINX1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr15:38,097,896...38,157,143
Ensembl chr15:38,097,886...38,157,140
|
|
G |
Pkib |
cAMP-dependent protein kinase inhibitor beta |
increases expression |
EXP |
Methylnitrosourea results in increased expression of PKIB mRNA |
CTD |
PMID:17341692 |
|
NCBI chr20:36,965,172...37,062,190
Ensembl chr20:36,905,340...37,062,187
|
|
G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PMAIP1 mRNA |
CTD |
PMID:18593901 |
|
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
|
|
G |
Pms2 |
PMS1 homolog 2, mismatch repair system component |
multiple interactions affects response to substance increases response to substance |
ISO |
Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein] PMS2 protein affects the susceptibility to Methylnitrosourea PMS2 protein results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:12967659 PMID:16204460 PMID:16426742 |
|
NCBI chr12:10,676,818...10,701,161
Ensembl chr12:10,676,764...10,701,066
|
|
G |
Polb |
DNA polymerase beta |
increases response to substance |
ISO |
POLB gene mutant form results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:17166880 |
|
NCBI chr16:69,379,438...69,402,710
Ensembl chr16:69,379,400...69,404,812
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases response to substance |
ISO |
PPARG gene mutant form results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:15930296 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ppp1r10 |
protein phosphatase 1, regulatory subunit 10 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of PPP1R10 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
|
|
G |
Praf2 |
PRA1 domain family, member 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PRAF2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr X:14,773,398...14,776,035
Ensembl chr X:14,773,420...14,775,909
|
|
G |
Prc1 |
protein regulator of cytokinesis 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PRC1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 1:134,250,086...134,271,765
Ensembl chr 1:134,250,081...134,271,765
|
|
G |
Prdm14 |
PR/SET domain 14 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of PRDM14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:6,082,163...6,092,712
Ensembl chr 5:6,082,442...6,092,712
|
|
G |
Prune1 |
prune exopolyphosphatase 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of PRUNE1 gene |
CTD |
PMID:16868089 |
|
NCBI chr 2:182,830,575...182,859,972
Ensembl chr 2:182,830,578...182,859,336
|
|
G |
Pten |
phosphatase and tensin homolog |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of PTEN mRNA |
CTD |
PMID:16616109 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of PTGS2 |
CTD |
PMID:28688903 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptpn14 |
protein tyrosine phosphatase, non-receptor type 14 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of PTPN14 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr13:101,268,258...101,420,508
Ensembl chr13:101,268,416...101,414,088
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases mutagenesis multiple interactions increases expression |
ISO EXP |
Methylnitrosourea results in increased mutagenesis of RARA gene Cholecalciferol inhibits the reaction [Methylnitrosourea results in increased expression of RARA mRNA] |
CTD |
PMID:16868089 PMID:21843606 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
increases phosphorylation |
EXP |
Methylnitrosourea results in increased phosphorylation of RB1 protein |
CTD |
PMID:15581186 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Rbck1 |
RANBP2-type and C3HC4-type zinc finger containing 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of RBCK1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:140,789,079...140,806,017
Ensembl chr 3:140,789,080...140,806,005
|
|
G |
Rbm4 |
RNA binding motif protein 4 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of RBM4 gene |
CTD |
PMID:16868089 |
|
NCBI chr 1:202,078,442...202,087,506
Ensembl chr 1:202,085,279...202,105,380
|
|
G |
Rbm43 |
RNA binding motif protein 43 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of RBM43 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:36,394,431...36,404,757
Ensembl chr 3:36,395,346...36,404,816
|
|
G |
Rbp4 |
retinol binding protein 4 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of RBP4 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Reg1a |
regenerating family member 1 alpha |
increases expression |
ISO |
Methylnitrosourea results in increased expression of REG1 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 4:110,892,451...110,895,115
Ensembl chr 4:110,892,453...110,895,570
|
|
G |
Reg3b |
regenerating family member 3 beta |
increases expression |
ISO |
Methylnitrosourea results in increased expression of REG3B mRNA |
CTD |
PMID:15240709 |
|
NCBI chr 4:110,861,775...110,865,015
Ensembl chr 4:110,861,775...110,865,015
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions affects activity affects localization decreases expression increases expression |
EXP |
3-aminobenzamide inhibits the reaction [Methylnitrosourea results in decreased expression of RELA protein modified form]; [Methylnitrosourea results in increased expression of NFKBIA protein] which affects the localization of RELA protein; tetramethylpyrazine promotes the reaction [Methylnitrosourea affects the localization of RELA protein] Methylnitrosourea affects the activity of RELA protein Methylnitrosourea results in decreased expression of RELA protein; Methylnitrosourea results in decreased expression of RELA protein modified form Methylnitrosourea results in increased expression of RELA protein |
CTD |
PMID:15960898 PMID:16098260 PMID:16762860 PMID:17137578 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rfx4 |
regulatory factor X4 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of RFX4 gene |
CTD |
PMID:16868089 |
|
NCBI chr 7:18,853,065...19,015,378
Ensembl chr 7:18,853,322...19,014,967
|
|
G |
Rhbdf2 |
rhomboid 5 homolog 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of RHBDF2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:101,833,157...101,860,283
Ensembl chr10:101,833,157...101,860,283
|
|
G |
Rnase1 |
ribonuclease A family member 1, pancreatic |
increases expression |
ISO |
Methylnitrosourea results in increased expression of RNASE1 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr15:24,361,924...24,363,633
Ensembl chr15:24,361,927...24,363,624
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased phosphorylation of RPS6KB1 protein |
CTD |
PMID:22465879 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
RT1-A2 |
RT1 class Ia, locus A2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of RT1-A2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr20:4,870,939...4,910,183
|
|
G |
Rxrg |
retinoid X receptor gamma |
affects expression |
EXP |
Methylnitrosourea affects the expression of RXRG mRNA |
CTD |
PMID:21843606 |
|
NCBI chr13:79,743,430...79,785,173
Ensembl chr13:79,743,563...79,785,167
|
|
G |
S100a3 |
S100 calcium binding protein A3 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of S100A3 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 2:176,034,283...176,089,702
Ensembl chr 2:176,049,520...176,089,702
|
|
G |
Scg2 |
secretogranin II |
increases expression |
EXP |
Methylnitrosourea results in increased expression of SCG2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 9:80,803,074...80,808,646
Ensembl chr 9:80,803,075...80,821,097
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of SCN10A mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Serpine2 |
serpin family E member 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of SERPINE2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of SGK1 mRNA |
CTD |
PMID:29110037 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Shc1 |
SHC adaptor protein 1 |
multiple interactions |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SHC1 mRNA; [Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SHC1 protein |
CTD |
PMID:22465879 |
|
NCBI chr 2:174,837,937...174,849,538
Ensembl chr 2:174,837,930...174,849,536
|
|
G |
Slc16a12 |
solute carrier family 16, member 12 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of SLC16A12 gene |
CTD |
PMID:16868089 |
|
NCBI chr 1:232,184,004...232,262,170
Ensembl chr 1:232,185,907...232,262,141
|
|
G |
Slc25a53 |
solute carrier family 25, member 53 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of SLC25A53 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr X:100,306,917...100,319,662
Ensembl chr X:100,306,915...100,319,863
|
|
G |
Slc26a4 |
solute carrier family 26 member 4 |
multiple interactions |
EXP |
Methylnitrosourea promotes the reaction [Iodine results in increased expression of SLC26A4 mRNA] |
CTD |
PMID:15922087 |
|
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
|
|
G |
Slc4a1ap |
solute carrier family 4 member 1 adaptor protein |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of SLC4A1AP mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:24,905,941...24,933,651
Ensembl chr 6:24,905,941...24,933,815
|
|
G |
Smad4 |
SMAD family member 4 |
increases response to substance |
ISO |
SMAD4 gene mutant form results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:12096346 |
|
NCBI chr18:67,243,742...67,274,438
Ensembl chr18:67,243,742...67,274,438
|
|
G |
Smad7 |
SMAD family member 7 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of SMAD7 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smg6 |
SMG6 nonsense mediated mRNA decay factor |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of SMG6 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:59,786,258...60,014,395
Ensembl chr10:59,786,258...60,014,395
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI1 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI1 mRNA] |
CTD |
PMID:25164625 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
multiple interactions decreases expression |
EXP ISO |
[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI2 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of SNAI2 mRNA] Methylnitrosourea results in decreased expression of SNAI2 mRNA |
CTD |
PMID:25164625 PMID:27221058 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Snrnp35 |
small nuclear ribonucleoprotein U11/U12 subunit 35 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of SNRNP35 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr12:32,112,032...32,119,829
Ensembl chr12:32,110,993...32,122,660
|
|
G |
Snrpc |
small nuclear ribonucleoprotein polypeptide C |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of SNRPC mRNA |
CTD |
PMID:25270620 |
|
NCBI chr20:5,888,453...5,906,638
Ensembl chr20:5,888,453...5,906,638
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of SOCS3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod2 |
superoxide dismutase 2 |
affects metabolic processing multiple interactions |
ISO |
Methylnitrosourea affects the metabolism of SOD2 protein PARP1 protein promotes the reaction [Methylnitrosourea affects the metabolism of SOD2 protein] |
CTD |
PMID:16052507 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
multiple interactions |
EXP |
[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of SOS1 mRNA |
CTD |
PMID:22465879 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Sphk1 |
sphingosine kinase 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of SPHK1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr10:101,758,567...101,764,240
Ensembl chr10:101,758,711...101,764,240
|
|
G |
Spink4 |
serine peptidase inhibitor, Kazal type 4 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of SPINK4 gene |
CTD |
PMID:16868089 |
|
NCBI chr 5:56,043,936...56,064,841
Ensembl chr 5:55,981,624...56,064,795
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of SPP1 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Spry2 |
sprouty RTK signaling antagonist 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of SPRY2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr15:82,692,291...82,697,408
Ensembl chr15:82,692,143...82,698,009
|
|
G |
Sptan1 |
spectrin, alpha, non-erythrocytic 1 |
increases cleavage |
EXP |
Methylnitrosourea results in increased cleavage of SPTAN1 protein |
CTD |
PMID:17069801 |
|
NCBI chr 3:13,241,164...13,306,047
Ensembl chr 3:13,241,217...13,306,046
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
multiple interactions increases expression |
EXP |
Hexachlorobenzene promotes the reaction [Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]]; Hexachlorobenzene promotes the reaction [Methylnitrosourea results in increased phosphorylation of SRC protein]; Methylnitrosourea inhibits the reaction [Hexachlorobenzene promotes the reaction [ESR1 protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [EGFR protein binds to SRC protein]; Methylnitrosourea promotes the reaction [Hexachlorobenzene promotes the reaction [EGFR protein binds to SRC protein]]; Methylnitrosourea promotes the reaction [Hexachlorobenzene results in increased phosphorylation of SRC protein]; Methylnitrosourea results in increased phosphorylation of and results in increased expression of SRC protein Methylnitrosourea results in increased expression of SRC protein |
CTD |
PMID:22245120 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
increases response to substance |
ISO |
STAT4 gene mutant form results in increased susceptibility to Methylnitrosourea |
CTD |
PMID:11418001 |
|
NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540
|
|
G |
Stmn1 |
stathmin 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of STMN1 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154
|
|
G |
Stmn2 |
stathmin 2 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of STMN2 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 2:93,204,690...93,252,011
Ensembl chr 2:93,204,692...93,252,011
|
|
G |
Syp |
synaptophysin |
affects expression |
EXP |
Methylnitrosourea affects the expression of SYP protein |
CTD |
PMID:18155124 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Tcrg |
T cell receptor gamma chain |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of TCRG gene |
CTD |
PMID:16868089 |
|
NCBI chr17:45,622,041...45,666,123
|
|
G |
Terc |
telomerase RNA component |
affects response to substance |
ISO |
TERC protein affects the susceptibility to Methylnitrosourea |
CTD |
PMID:14612493 |
|
NCBI chr 2:112,815,654...112,816,041
|
|
G |
Tff2 |
trefoil factor 2 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of TFF2 mRNA |
CTD |
PMID:15240709 |
|
NCBI chr20:9,215,750...9,219,619
Ensembl chr20:9,215,761...9,219,619
|
|
G |
Tgif1 |
TGFB-induced factor homeobox 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of TGIF1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802
|
|
G |
Thpo |
thrombopoietin |
multiple interactions increases expression |
ISO |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of THPO protein] |
CTD |
PMID:16822543 |
|
Ensembl chr11:80,182,820...80,188,167
|
|
G |
Thra |
thyroid hormone receptor alpha |
affects expression |
EXP |
Methylnitrosourea affects the expression of THRA mRNA |
CTD |
PMID:21843606 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
affects expression |
EXP |
Methylnitrosourea affects the expression of THRB mRNA |
CTD |
PMID:21843606 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Thrsp |
thyroid hormone responsive |
decreases expression increases expression |
EXP |
Methylnitrosourea results in decreased expression of THRSP mRNA Methylnitrosourea results in increased expression of THRSP mRNA |
CTD |
PMID:16525678 PMID:17341692 |
|
NCBI chr 1:151,723,415...151,727,740
Ensembl chr 1:151,723,086...151,728,075
|
|
G |
Thumpd3 |
THUMP domain containing 3 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of THUMPD3 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 4:146,185,422...146,209,802
Ensembl chr 4:146,185,503...146,211,246
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of TIMP1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tinagl1 |
tubulointerstitial nephritis antigen-like 1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of TINAGL1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 5:142,513,710...142,523,730
Ensembl chr 5:142,513,714...142,523,720
|
|
G |
Tkt |
transketolase |
increases expression |
EXP |
Methylnitrosourea results in increased expression of TKT mRNA |
CTD |
PMID:16525678 |
|
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
|
|
G |
Tmem69 |
transmembrane protein 69 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of TMEM69 gene |
CTD |
PMID:16868089 |
|
NCBI chr 5:130,004,888...130,008,466
Ensembl chr 5:130,004,901...130,010,655
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of TNF protein] Methylnitrosourea results in increased expression of TNF mRNA |
CTD |
PMID:16822543 PMID:28688903 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfrsf11b |
TNF receptor superfamily member 11B |
decreases expression |
EXP |
Methylnitrosourea results in decreased expression of TNFRSF11B mRNA |
CTD |
PMID:17341692 |
|
NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
|
|
G |
Tnfrsf12a |
TNF receptor superfamily member 12A |
increases expression |
EXP |
Methylnitrosourea results in increased expression of TNFRSF12A mRNA |
CTD |
PMID:17412507 |
|
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
|
|
G |
Tnip2 |
TNFAIP3 interacting protein 2 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of TNIP2 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr14:76,228,350...76,245,553
Ensembl chr14:76,228,371...76,275,265
|
|
G |
Top2a |
DNA topoisomerase II alpha |
increases expression |
ISO |
Methylnitrosourea results in increased expression of TOP2A mRNA |
CTD |
PMID:25270620 |
|
NCBI chr10:83,945,731...83,976,874
Ensembl chr10:83,945,735...83,976,874
|
|
G |
Top3b |
DNA topoisomerase III beta |
decreases expression increases expression |
ISO |
Methylnitrosourea results in decreased expression of TOP3B mRNA Methylnitrosourea results in increased expression of TOP3B mRNA |
CTD |
PMID:16616109 PMID:25270620 |
|
NCBI chr11:84,097,018...84,125,474
Ensembl chr11:84,097,026...84,125,392
|
|
G |
Tor1b |
torsin family 1, member B |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of TOR1B mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:14,243,181...14,249,279
Ensembl chr 3:14,243,243...14,249,272
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions increases expression increases phosphorylation increases response to substance affects response to substance increases stability |
EXP ISO |
[Estradiol co-treated with Methylnitrosourea co-treated with Progesterone] results in decreased expression of TP53 mRNA; [Methylnitrosourea co-treated with Progesterone] results in decreased expression of TP53 mRNA; Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TP53 protein] Methylnitrosourea results in increased expression of TP53 mRNA Butylated Hydroxyanisole inhibits the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; MAPK8 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; MGMT protein inhibits the reaction [TRP53 gene mutant form results in increased susceptibility to Methylnitrosourea]; MSH2 protein promotes the reaction [Methylnitrosourea results in increased phosphorylation of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the activity of TRP53 protein]; PARP1 protein affects the reaction [Methylnitrosourea affects the expression of TRP53 protein] TRP53 protein affects the susceptibility to Methylnitrosourea Methylnitrosourea results in increased expression of and results in increased phosphorylation of TP53 protein; TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein] Methylnitrosourea results in increased stability of TP53 protein |
CTD |
PMID:11536039 PMID:11850828 PMID:12185594 PMID:17412507 PMID:18593901 PMID:20732338 PMID:21285353 PMID:27233451 PMID:28688903 PMID:29110037 More...
|
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53bp1 |
tumor protein p53 binding protein 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of TP53BP1 protein |
CTD |
PMID:27233451 |
|
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of TRP53INP1 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 5:24,253,986...24,272,250
Ensembl chr 5:24,260,568...24,267,968
|
|
G |
Trip6 |
thyroid hormone receptor interactor 6 |
decreases expression |
ISO |
Methylnitrosourea results in decreased expression of TRIP6 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr12:19,386,212...19,390,619
Ensembl chr12:19,386,014...19,390,618
|
|
G |
Tspo |
translocator protein |
increases expression |
EXP |
Methylnitrosourea results in increased expression of TSPO mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
G |
Ttk |
Ttk protein kinase |
increases expression |
ISO |
Methylnitrosourea results in increased expression of TTK mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 8:84,754,329...84,792,653
Ensembl chr 8:84,754,315...84,792,651
|
|
G |
Twist1 |
twist family bHLH transcription factor 1 |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of TWIST1 mRNA] |
CTD |
PMID:25164625 |
|
NCBI chr 6:50,674,910...50,676,904
Ensembl chr 6:50,674,678...50,677,653
|
|
G |
Tyr |
tyrosinase |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of TYR gene |
CTD |
PMID:17174358 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Tyrp1 |
tyrosinase-related protein 1 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of TYRP1 gene |
CTD |
PMID:17174358 |
|
NCBI chr 5:95,280,982...95,299,516
Ensembl chr 5:95,280,982...95,299,516
|
|
G |
Ubac2 |
UBA domain containing 2 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of UBAC2 gene |
CTD |
PMID:16868089 |
|
NCBI chr15:98,960,139...99,107,795
Ensembl chr15:98,960,139...99,107,787
|
|
G |
Ube2c |
ubiquitin-conjugating enzyme E2C |
increases expression |
ISO |
Methylnitrosourea results in increased expression of UBE2C mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:153,506,636...153,513,339
|
|
G |
Ube2j1 |
ubiquitin-conjugating enzyme E2, J1 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of UBE2J1 mRNA |
CTD |
PMID:17412507 |
|
NCBI chr 5:47,422,476...47,441,476
Ensembl chr 5:47,422,587...47,441,461
|
|
G |
Upp1 |
uridine phosphorylase 1 |
increases expression decreases expression |
EXP ISO |
Methylnitrosourea results in increased expression of UPP1 mRNA Methylnitrosourea results in decreased expression of UPP1 mRNA |
CTD |
PMID:17412507 PMID:25270620 |
|
NCBI chr14:83,809,495...83,829,299
Ensembl chr14:83,809,960...83,829,462
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions increases expression |
ISO EXP |
Butylated Hydroxytoluene inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]; Freund's Adjuvant inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein]; IFNG protein inhibits the reaction [Methylnitrosourea results in increased expression of VEGFA protein] [Methylnitrosourea co-treated with Estradiol] results in increased expression of VEGFA mRNA; [Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of VEGFA mRNA; [Methylnitrosourea co-treated with Progesterone] results in increased expression of VEGFA mRNA |
CTD |
PMID:16822543 PMID:20732338 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions |
EXP |
[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM mRNA; [Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM protein; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM mRNA]; Quercetin inhibits the reaction [[Methylnitrosourea co-treated with Testosterone] results in increased expression of VIM protein] |
CTD |
PMID:25164625 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Vrk1 |
VRK serine/threonine kinase 1 |
decreases expression multiple interactions |
ISO |
Methylnitrosourea results in decreased expression of VRK1 protein TP53 protein promotes the reaction [Methylnitrosourea results in decreased expression of VRK1 protein] |
CTD |
PMID:27233451 |
|
NCBI chr 6:124,914,770...124,981,508
Ensembl chr 6:124,914,855...124,981,436
|
|
G |
Wdr35 |
WD repeat domain 35 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of WDR35 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr 6:31,771,315...31,831,450
Ensembl chr 6:31,771,360...31,831,029
|
|
G |
Wnt5a |
Wnt family member 5A |
increases expression increases expression |
EXP |
Methylnitrosourea results in increased expression of WNT5A mRNA N-methyl-N-nitrosourea increases expression of Wnt5a mRNA in colon |
CTD RGD |
PMID:17341692 PMID:28032729 |
RGD:150530464 |
NCBI chr16:3,697,032...3,718,230
Ensembl chr16:3,697,032...3,718,234
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases response to substance |
ISO |
XIAP protein results in decreased susceptibility to Methylnitrosourea |
CTD |
PMID:12766084 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
G |
Xrcc5 |
X-ray repair cross complementing 5 |
increases mutagenesis |
ISO |
Methylnitrosourea results in increased mutagenesis of XRCC5 gene |
CTD |
PMID:16868089 |
|
NCBI chr 9:73,955,216...74,044,020
Ensembl chr 9:73,955,216...74,044,018
|
|
G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of ZEB1 mRNA |
CTD |
PMID:27221058 |
|
NCBI chr17:51,948,948...52,116,018
Ensembl chr17:51,948,948...52,115,214
|
|
G |
Zfp365 |
zinc finger protein 365 |
increases expression |
ISO |
Methylnitrosourea results in increased expression of ZFP365 mRNA |
CTD |
PMID:25270620 |
|
NCBI chr20:20,666,240...20,689,734
Ensembl chr20:20,666,240...20,691,238
|
|
G |
Znf8 |
zinc finger protein 8 |
increases expression |
EXP |
Methylnitrosourea results in increased expression of ZFP128 mRNA |
CTD |
PMID:16525678 |
|
NCBI chr 1:73,498,526...73,511,929
Ensembl chr 1:73,498,491...73,511,119
|
|